a developer of novel therapies for the treatment of retinal disease
Industry Biotechnology
A.I.dvisor indicates that over the last year, KOD has been loosely correlated with AKBA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then AKBA could also see price increases.
Ticker / NAME | Correlation To KOD | 1D Price Change % | ||
---|---|---|---|---|
KOD | 100% | +9.24% | ||
AKBA - KOD | 41% Loosely correlated | +1.63% | ||
IMNM - KOD | 40% Loosely correlated | -3.38% | ||
MGTX - KOD | 39% Loosely correlated | +1.91% | ||
BEAM - KOD | 39% Loosely correlated | -1.21% | ||
RXRX - KOD | 39% Loosely correlated | -4.30% | ||
More |